Par-4 induces cholinergic hypoactivity by suppressing ChAT protein synthesis and inhibiting NGF-inducibility of ChAT activity

被引:14
作者
Guo, Q
Xie, J
Du, HM
机构
[1] Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Neurobiol & Pharmacol, Rootstown, OH 44272 USA
[2] Case Western Reserve Univ, Dept Human Genet, Cleveland, OH 44106 USA
关键词
Alzheimer's disease; Par-4; choline acetyl-transferase; nerve growth factor; amyloid beta peptide; neurotransmitter;
D O I
10.1016/S0006-8993(00)02559-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Profound reductions in choline acetyl-transferase (ChAT) activity are reliable markers for cholinergic hypoactivity associated with cognitive function deficit in Alzheimer's disease (AD). Par-4 (prostate apoptosis response-4) is a novel mediator of neuronal apoptosis associated with the pathogenesis of AD. Par-4 contains a leucine zipper domain (Leu.zip) that presumably mediates protein-protein interactions critical for its functions in apoptosis. Par-4 activity can be effectively blocked by overexpression of Leu.zip because it exerts a dominant negative action possibly by competitively blocking the interaction of Par-4 wit other proteins. Whether Par-4 participates in regulation of cholinergic signaling has not been determined. We report that overexpression of Par-4 results in apoptotic and non-apoptotic reductions in ChAT activity in transfected PC12 cells following exposure to a toxic concentration (50 mu M) of aggregated amyloid beta peptide 1-42 (A beta 1-42) and a nan-toxic concentration (1 mu M) of soluble A beta 1-42, respectively. Non-apoptotic reduction in ChAT activity induced by Par-4 can be completely blocked by co-overexpression of Leu.zip, indicating that enhanced Par-4 activity is a necessary event for cholinergic hypoactivity in PC12 cells. Further studies found that Par-4 induces non-apoptotic reduction in ChAT activity by: (1) reducing ChAT protein levels following exposure to non-toxic concentration of A beta, and (2) blocking the cellular capability to increase ChAT activity following exposure to nerve growth factor (NGF). The role of Par-4 in inducing cholinergic hypoactivity may have significant implications in the understanding and the treatment of memory impairment in AD. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:221 / 232
页数:12
相关论文
共 85 条
[11]  
de la Monte SM, 1999, J NEURAL TRANSM-SUPP, P1
[12]   Alzheimer-associated presenilin-2 confers increased sensitivity to apoptosis in PC12 cells [J].
Deng, GM ;
Pike, CJ ;
Cotman, CW .
FEBS LETTERS, 1996, 397 (01) :50-54
[13]   The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C [J].
DiazMeco, MT ;
Municio, MM ;
Frutos, S ;
Sanchez, P ;
Lozano, J ;
Sanz, L ;
Moscat, J .
CELL, 1996, 86 (05) :777-786
[14]   Alzheimer disease -: Mouse models pave the way for therapeutic opportunities [J].
Emilien, G ;
Maloteaux, JM ;
Beyreuther, K ;
Masters, CL .
ARCHIVES OF NEUROLOGY, 2000, 57 (02) :176-181
[15]   The neurobiology and pharmacotherapy of Alzheimer's disease [J].
Felician, O ;
Sandson, TA .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1999, 11 (01) :19-31
[16]   APOPTOSIS MEDIATED NEUROTOXICITY INDUCED BY CHRONIC APPLICATION OF BETA-AMYLOID FRAGMENT 25-35 [J].
FORLONI, G ;
CHIESA, R ;
SMIROLDO, S ;
VERGA, L ;
SALMONA, M ;
TAGLIAVINI, F ;
ANGERETTI, N .
NEUROREPORT, 1993, 4 (05) :523-526
[17]   Clinical features of Alzheimer's disease [J].
Förstl, H ;
Kurz, A .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1999, 249 (06) :288-290
[18]   The cholinergic hypothesis of Alzheimer's disease: a review of progress [J].
Francis, PT ;
Palmer, AM ;
Snape, M ;
Wilcock, GK .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (02) :137-147
[19]   Progress toward valid transgenic mouse models for Alzheimer's disease [J].
Guénette, SY ;
Tanzi, RE .
NEUROBIOLOGY OF AGING, 1999, 20 (02) :201-211
[20]  
Guo Q, 1999, J NEUROSCI RES, V56, P457, DOI 10.1002/(SICI)1097-4547(19990601)56:5<457::AID-JNR2>3.0.CO